Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2015 2
2016 7
2017 6
2018 7
2019 3
2020 3
2021 8
2022 11
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis.
Alten R, Burmester GR, Matucci-Cerinic M, Salmon JH, Lopez-Romero P, Fakhouri W, de la Torre I, Zaremba-Pechmann L, Holzkämper T, Fautrel B. Alten R, et al. Among authors: salmon jh. Rheumatol Ther. 2023 Feb;10(1):73-93. doi: 10.1007/s40744-022-00500-6. Epub 2022 Oct 13. Rheumatol Ther. 2023. PMID: 36227530 Free PMC article.
A case of arthritis under pembrolizumab.
Salmon JH, Lambrecht I, Brochot P, Grange F. Salmon JH, et al. Joint Bone Spine. 2017 Mar;84(2):243-244. doi: 10.1016/j.jbspin.2016.03.003. Epub 2016 Apr 23. Joint Bone Spine. 2017. PMID: 27118015 Review. No abstract available.
No more than meets the eye.
Dormegnie LP, Henry A, Salmon JH, N'Guyen Y. Dormegnie LP, et al. Among authors: salmon jh. Eur J Intern Med. 2021 May;87:90-91. doi: 10.1016/j.ejim.2021.03.022. Epub 2021 Apr 1. Eur J Intern Med. 2021. PMID: 33814274 No abstract available.
Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study.
Guillo L, Flachaire B, Avouac J, Dong C, Nachury M, Bouguen G, Buisson A, Caillo L, Fumery M, Gilletta C, Hébuterne X, Lafforgue P, Laharie D, Mahé E, Marotte H, Nancey S, Ottaviani S, Salmon JH, Savoye G, Serrero M, Uzzan M, Viguier M, Richez C, Peyrin-Biroulet L, Seksik P, Pham T; COMBIO Study Group. Guillo L, et al. Among authors: salmon jh. Dig Liver Dis. 2023 Jan;55(1):61-68. doi: 10.1016/j.dld.2022.07.012. Epub 2022 Aug 16. Dig Liver Dis. 2023. PMID: 35985961
Association between hidradenitis suppurativa and spondyloarthritis.
Fauconier M, Reguiai Z, Barbe C, Colosio A, Eschard JP, Salmon JH, Direz G. Fauconier M, et al. Among authors: salmon jh. Joint Bone Spine. 2018 Oct;85(5):593-597. doi: 10.1016/j.jbspin.2017.09.005. Epub 2017 Sep 28. Joint Bone Spine. 2018. PMID: 28965938
Recommendations for assessing the risk of cardiovascular disease and venous thromboembolism before the initiation of targeted therapies for chronic inflammatory rheumatic diseases.
Avouac J, Fogel O, Hecquet S, Daien C, Elalamy I, Picard F, Prati C, Salmon JH, Truchetet ME, Sellam J, Molto A; behalf of the French Society of Rheumatology. Avouac J, et al. Among authors: salmon jh. Joint Bone Spine. 2023 Sep;90(5):105592. doi: 10.1016/j.jbspin.2023.105592. Epub 2023 May 16. Joint Bone Spine. 2023. PMID: 37201575 Free article.
Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients.
Alten R, Burmester GR, Matucci-Cerinic M, Salmon JH, Östör A, Ng KJ, Gerwien J, Zaremba-Pechmann L, Brnabic AJM, Fautrel B. Alten R, et al. Among authors: salmon jh. Rheumatol Ther. 2023 Dec;10(6):1575-1595. doi: 10.1007/s40744-023-00597-3. Epub 2023 Sep 27. Rheumatol Ther. 2023. PMID: 37755648 Free PMC article.
Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission.
Kedra J, Dieudé P, Giboin C, Marotte H, Salliot C, Schaeverbeke T, Perdriger A, Soubrier M, Morel J, Constantin A, Dernis E, Royant V, Salmon JH, Pham T, Gottenberg JE, Pertuiset E, Dougados M, Devauchelle-Pensec V, Gaudin P, Cormier G, Goupille P, Mariette X, Berenbaum F, Alcaix D, Rouidi SA, Berthelot JM, Monnier A, Piroth C, Lioté F, Goëb V, Gaujoux-Viala C, Chary-Valckenaere I, Hajage D, Tubach F, Fautrel B; CRI‐IMIDIATE clinical research network. Kedra J, et al. Among authors: salmon jh. Arthritis Rheumatol. 2024 Apr;76(4):541-552. doi: 10.1002/art.42752. Epub 2024 Jan 25. Arthritis Rheumatol. 2024. PMID: 37942714 Clinical Trial.
Prevalence and Impact of Rheumatologic Pain in Cystic Fibrosis Adult Patients.
Schmoll A, Launois C, Perotin JM, Ravoninjatovo B, Griffon M, Carré S, Mulette P, Ancel J, Hagenburg J, Lebargy F, Deslée G, Salmon JH, Dury S. Schmoll A, et al. Among authors: salmon jh. Front Med (Lausanne). 2022 Feb 8;8:804892. doi: 10.3389/fmed.2021.804892. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35211488 Free PMC article.
48 results